BNR Stock Earnings: Burning Rock Biotech Q4 2023 Results
Burning Rock Biotech reported an earnings per share of -22 cents and revenue of $17.05 million. For concerns, contact [email protected].
- Latest
- Trending
Burning Rock Biotech reported an earnings per share of -22 cents and revenue of $17.05 million. For concerns, contact [email protected].
Resources Management Corp CT ADV increased its position in SPDR S&P Biotech ETF by 1,715.8% in Q2. Fortis Capital Advisors ...
Orchestra BioMed Holdings, Inc. financial report: Stock closed at $5.00, 52-week range $4.26-$23.39, market cap $188.013M. No dividends. Latest data ...
Pesticides harm ecosystems by killing various insects, not just targeted ones. The mayor of Suzano hopes for a 20% reduction ...
LG plans to invest $74.3 billion in South Korea through 2028, focusing on AI, biotechnology, batteries, clean tech, and displays. ...
Adial Pharmaceuticals, Inc. - A biopharmaceutical company focusing on addiction therapeutics. Stock faced challenges this year, with price drops. Leadership ...
Discover the financial report of Theratechnologies Inc., a biopharmaceutical company specializing in healthcare therapies. Learn about their market cap, leadership ...
22nd Century Group, Inc. (XXII): A promising tobacco industry player with innovative plant science focus, solid financials & growth potential. ...
Thomas H. Fagley appointed as the national biotech sector leader, highlighting the company's efforts to improve in crucial areas. R. ...
Contrary to stereotypes, IP jobs aren’t just for scientists in labs. Allowing our IP system to wither away puts millions ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.